Ackrell Capital Cannabis Investment Report Shows Strong Stock Gains Post‑Trump Election
Summary
The document is a routine market analysis of publicly traded cannabis companies with no mention of specific individuals, transactions, or wrongdoing. It offers no actionable investigative leads and re U.S. cannabis‑related stocks rose sharply from late 2016 through 2017. The report notes that the election of Donald Trump and appointment of Jeff Sessions did not dampen p Data sourced from S&P Globa
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (2)
Tags
Related Documents (6)
Cannabis Investment Report shows stock gains tied to political announcements
The passage merely reports market performance linked to publicly known political events (Trudeau's legalization plan, Trump election, Sessions appointment) and a corporate investment. It offers no con Canadian cannabis stocks rose after Prime Minister Justin Trudeau announced recreational legalizatio U.S. cannabis stocks remained resilient despite Donald Trump's election and Jeff Sessions as Attor
Cannabis Investment Report – Comparison of U.S. Stock Market Listing Requirements (Dec 2017)
The passage only provides generic data on listing standards for Nasdaq, NYSE, and OTC markets. It contains no references to influential actors, financial flows, misconduct, or investigative leads. Most cannabis‑related public companies trade on the OTC due to looser requirements. Nasdaq and NYSE have higher minimum share prices and stricter governance standards. OTC tiers (OTCQX, OTCQB, OTCPink) v
Ackrell Capital Cannabis Investment Report shows rapid stock price gains and capital raises in Canadian cannabis sector (Dec 2017)
The document is a market performance summary with no specific allegations, names of wrongdoing, or actionable leads linking powerful actors to misconduct. It merely reports stock price movements and c Canadian cannabis stocks experienced massive price increases in 2017. Capital raised by publicly traded Canadian cannabis companies is quantified for the 12‑month period The report is produced by Ac
Ackrell Capital report shows modest capital raised by U.S. publicly traded cannabis companies in 2017
The passage provides only aggregate financial data on small, largely unprofitable cannabis firms with no mention of high‑profile individuals, government agencies, or illicit activity. It lacks specifi Only $268 million total equity and debt raised by listed cannabis firms in the 12‑month period endin Most companies had little to no revenue and were not profitable. A single large $317 million finan
Directory of Private Cannabis Companies Featured in House Oversight Report
The passage lists several private cannabis producers and their products without mentioning any high‑profile individuals, government agencies, financial transactions, or alleged misconduct. It offers n Level Blends – California cannabis concentrate producer. Lunchbox Alchemy – Oregon cannabis edibles and concentrates maker. LivWell Enlightened Health – Colorado/ Oregon dispensary operator and culti
Cannabis Industry Company Listings in 2017 Investment Report
The passage lists several small cannabis businesses and a research firm with no mention of high‑profile officials, financial misconduct, or controversial actions. It provides no actionable leads, date Identifies Auntie Dolores, a cannabis edibles producer in Oakland, CA. Lists BAS Research, a cannabis oil extraction and manufacturing firm in Berkeley, CA. Mentions Baker Technologies, a CRM platfor
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.